Document Detail


Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome.
MedLine Citation:
PMID:  15507969     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The association between the detection of Mycoplasma hominis or Ureaplasma urealyticum in midtrimester amniotic fluid and amniotic fluid cytokine concentrations and subsequent pregnancy outcome were examined. STUDY DESIGN: Amniocentesis was performed between 15 and 19 weeks of gestation in 179 asymptomatic women. Aliquots were assayed for M hominis and U urealyticum by polymerase chain reaction coupled to enzyme-linked immunosorbent assay. Intra-amniotic levels of interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, interleukin-6, and tumor necrosis factor-alpha were determined by enzyme-linked immunosorbent assay. Pregnancy outcomes were obtained after the completion of all testing. RESULTS: U urealyticum was detected in 22 of 172 amniotic fluids (12.8%); M hominis was present in 11 of 179 amniotic fluids (6.1%). There was no relationship between U urealyticum detection and the concentration of any cytokine. Detection of M hominis was associated with elevated intra-amniotic concentrations of interleukin-4 ( P = .01). Preterm premature rupture of membranes that was followed by preterm birth occurred in 5 women (2.8%); 5 women (2.8%) had a spontaneous preterm birth with intact membranes. All 5 of the women with preterm premature rupture of membranes (100%) tested positive for either U urealyticum or M hominis , as opposed to none of the women with spontaneous preterm birth and to 27 of 161 women (16.8%) with a term birth ( P = .0002). CONCLUSION: The detection of M hominis or U urealyticum in midtrimester amniotic fluid by polymerase chain reaction-enzyme-linked immunosorbent assay may be a risk factor for subsequent preterm premature rupture of membranes.
Authors:
Sriram C Perni; Santosh Vardhana; Irina Korneeva; Sara L Tuttle; Lilly-Rose Paraskevas; Stephen T Chasen; Robin B Kalish; Steven S Witkin
Related Documents :
20040809 - Amniotic fluid embolism.
2193269 - Standardized measurement of amniotic fluid volume by correlation of sonography with dye...
19683759 - Is cystatin c a promising parameter to determine postnatal outcome of prenatally diagno...
17506369 - Amniotic fluid index as a predictor of adverse perinatal outcome in the hellp syndrome.
10368489 - Perinatal risks associated with borderline amniotic fluid index.
4048069 - Exclusion of citrullinaemia in the first trimester of pregnancy by direct assay of argi...
7145279 - Clinical test for placenta in 300 consecutive menstrual aspirations.
19032689 - Sperm disomy in idiopathic severely oligoasthenoteratozoospermic males.
24779239 - Clinical characteristics and reproductive outcome following hysteroscopic adhesiolysis ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  191     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-27     Completed Date:  2004-12-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1382-6     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Weill Medical College of Cornell University, 525 East 68th Street, New York, NY 10021, USA. scperni@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Amniotic Fluid / chemistry*,  microbiology*
Cytokines / analysis*
Enzyme-Linked Immunosorbent Assay
Female
Fetal Membranes, Premature Rupture / epidemiology,  microbiology
Humans
Mycoplasma hominis / isolation & purification*
Polymerase Chain Reaction
Pregnancy
Pregnancy Outcome / epidemiology
Pregnancy Trimester, Second
Risk Factors
Ureaplasma urealyticum / isolation & purification*
Chemical
Reg. No./Substance:
0/Cytokines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity...
Next Document:  Maternal infection-induced white matter injury is reduced by treatment with interleukin-10.